SCHEMBL26817828

SCHEMBL26817828

C=C(Cn1cnc2ccccc21)N=[N+]=[N-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ LMNA P02545 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ FDPS P14324 2/20 0.46
▸ GGPS1 O95749 1/20 0.46
▸ TNF P01375 1/20 0.45
▸ CYP11B1 P15538 1/20 0.45
▸ CYP11B2 P19099 1/20 0.45
▸ EGLN3 Q9H6Z9 1/20 0.44
▸ ALPL P05186 2/20 0.44
▸ ALPG P10696 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ALPI P09923 1/20 0.44
▸ PLAA Q9Y263 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26817876 0.86 EGLN3 (0.56) TDP1KDM4ELMNASMN1; SMN2L3MBTL1
SCHEMBL26817874 0.84 TDP1 (0.53) TDP1NPC1LMNASMN1; SMN2L3MBTL1
SCHEMBL7160203 0.77 TDP1 (0.61) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL26818584 0.75 KDM4E (0.60) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL7732690 0.75 TDP1 (0.59) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL2882482 0.75 TDP1 (0.59) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL11498670 0.75 KDM4E (0.56) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL8017568 0.73 TDP1 (0.56) TDP1KDM4ENPC1LMNASMN1; SMN2
SCHEMBL26817834 0.72 LMNA (0.50) TDP1NPC1LMNASMN1; SMN2TNF
SCHEMBL27864830 0.72 TDP1 (0.63) TDP1KDM4ENPC1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING Changzhou University (CN) 2023-11-30 — — US disclosed
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING Changzhou University (CN) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING PTMS, CBS, CHAMP1 TDP1 4627/4885KDM4E 4700/4885NPC1 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback